Based on these findings, we hypothesize that inhibiting MDH2 could modulate tumor growth and metastasis by disrupting the NAD/NADH equilibrium and malate-aspartate transport between the cytoplasm and mitochondria, thereby altering the energy metabolism of cancer cells. This evidence concerns the gene MDH2 and cancer.